Company · CIK 0000946644 · SIC 2836 — Biological Products, (No Diagnostic Substances) · NYSE
AIM ImmunoTech Inc. · AIM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 PForm 4 → | Sep 18, 8:30 am EDT | Thomas K EquelsCEO & President, Director | 24,000 | $0.208 | $4,992 | 126,822 | +23.3% | |
| Sep 16, 2026 PForm 4 → | Sep 17, 12:01 pm EDT | Thomas K EquelsCEO & President, Director | 11,000 | $0.21 | $2,310 | 102,822 | +12.0% | |
| Sep 15, 2026 PForm 4 → | Sep 16, 9:15 am EDT | Thomas K EquelsCEO & President, Director | 22,000 | $0.221 | $4,862 | 91,822 | +31.5% | |
| Sep 14, 2026 PForm 4 → | Sep 15, 4:30 pm EDT | Thomas K EquelsCEO & President, Director | 5,900 | $0.219 | $1,292 | 69,822 | +9.23% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.